Belsky Marc 4
4 · Kezar Life Sciences, Inc. · Filed Feb 5, 2020
Insider Transaction Report
Form 4
Belsky Marc
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-02-04$2.60/sh+15,384$39,998→ 15,384 total
Holdings
- 2,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Shares were purchased in a public offering of the Issuer at a public offering price of $2.60.